October 2021 FDA Recall Drug by Akorn, Inc.
D-0004-2022 - Microbial Contamination of Sterile Products

This Class II drug recall was voluntarily initiated by Akorn, Inc. on October 4, 2021 for the product Drug. The FDA reported the reason for recall as microbial contamination of sterile products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0004-2022

Reason for Recall
Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.
Initiated
10-04-2021
Reported
10-13-2021
Quantity
10,210 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Distributed Nationwide in the USA
Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11

Batch or Lot Expiration Information

Lot# Lot 0B61A, Exp 01/31/2022